Features of ultrasound of endometrial pathological conditions in breast cancer patients receiving tamoxifen: a review of literature
The article examines the possibilities and features of ultrasound in the diagnosis of endometrial pathological conditions on the background of taking tamoxifen in women diagnosed with breast cancer based on data obtained from studying the sources of domestic and foreign literature from 1994 to 2018.
Saved in:
Main Authors: | M. A. Chekalova (Author), M. I. Borisova (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endometrial ablation for prevention of recurrent endometrial pathology in postmenopausal breast cancer patients receiving tamoxifen
by: I O Mamikonyan, et al.
Published: (2015) -
Features of ovarian steroidogenesis and endometrial hypertrophy during adjuvant therapy with tamoxifen in premenopausal patients with hormone-dependent breast cancer
by: A. Yu. Goryainova, et al.
Published: (2023) -
Uterine Fibroid in Breast Cancer Patients receiving Tamoxifen Therapy
by: Rismawati Tambunan, et al.
Published: (2021) -
Ultrasound method in the diagnosis of ovarian neoplasms in patients with endometrial cancer
by: M. A. Chekalova, et al.
Published: (2017) -
Secretory Endometrial Adenocarcinoma in a Tamoxifen User With Breast Cancer After Menopause
by: Chia-Jen Wu, et al.
Published: (2007)